Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
23Andme Holding Co.
(NQ:
ME
)
0.2918
-0.0080 (-2.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
October 08, 2024
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risks
From
23andMe, Inc.
Via
GlobeNewswire
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
October 02, 2024
Lawyer raises objections to 23andMe's proposed $30 million settlement, arguing it undermines arbitration rights for 5,000 customers following a data breach. The court is set to review the case in late...
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
Looking Into 23andMe Holding's Recent Short Interest
June 12, 2024
Via
Benzinga
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
September 25, 2024
Provides 23andMe+ Premium members with insight into their likelihood of experiencing emotional eating based on their genetics
From
23andMe, Inc.
Via
GlobeNewswire
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
September 18, 2024
23andMe's independent board members resigned after months of waiting for Anne Wojcicki's fully financed proposal to take the company private.
Via
Benzinga
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
September 18, 2024
Via
Benzinga
Independent Directors of 23andMe Resign from Board
September 17, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
September 15, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
September 15, 2024
From
23andMe, Inc.
Via
GlobeNewswire
One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations
September 12, 2024
23andMe, National Human Genome Research Institute, and Johns Hopkins University conducted collaborative research that studied sickle cell trait in a diverse population
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 03, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 29, 2024
Via
Benzinga
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
August 28, 2024
In conjunction with this new offering, 23andMe, Lemonaid Health’s parent company, recently launched study focused on the role genetics may play in effectiveness and side effects of GLP-1s
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
August 08, 2024
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe
August 02, 2024
23andMe stock is up on Friday as investors react to an offer from the company's founder to take it private for 40 cents per share for ME.
Via
InvestorPlace
23andMe Special Committee responds to CEO’s take-private proposal
August 02, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
July 25, 2024
Study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer
From
23andMe, Inc.
Via
GlobeNewswire
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
23ANDME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 23andMe Holding Co. - ME
July 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
July 11, 2024
Hercules Capital, Pfizer and Target offer stability, growth potential and reliable dividends in the realm of high-dividend stocks.
Via
InvestorPlace
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From
23andMe, Inc.
Via
GlobeNewswire
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
June 27, 2024
Business development companies can be a lucrative source of passive income.
Via
The Motley Fool
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year.
Via
InvestorPlace
23andMe Launches New Genetic Report on Bipolar Disorder
June 05, 2024
Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variants
From
23andMe, Inc.
Via
GlobeNewswire
Why 23andMe Stock Tumbled 10% on Tuesday
June 04, 2024
Is altruism a good idea for an unprofitable capitalistic enterprise?
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.